Correction to "CALHM2 V136G polymorphism reduces astrocytic ATP release and is associated with depressive symptoms and Alzheimer's disease risk". . Alzheimers Dement 2024 Jun 23. doi: 10.1002/alz.13822.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Correction to "CALHM2 V136G polymorphism reduces astrocytic ATP release and is associated with depressive symptoms and Alzheimer's disease risk". Alzheimers Dement 2024 Jun 23. doi: 10.1002/alz.13822.
PMID: 38923157